# Metformin in Diabetic Patients Undergoing Coronary Angiography

Study · id `cardio:ct-nct04766008` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04766008](<https://clinicaltrials.gov/study/NCT04766008>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04766008

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT04766008. Allocation not applicable; no masking; primary purpose prevention. Start 2020-01-15 (actual); primary completion 2022-04-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT04766008, source copy `cardio:ctgov-nct04766008-2022-04-12`, retrieved 2026-10-26)
- Started: 2020-01-15 (actual) (ClinicalTrials.gov record NCT04766008, source copy `cardio:ctgov-nct04766008-2022-04-12`, retrieved 2026-10-26)
- Primary completion: 2022-04-11 (actual) (ClinicalTrials.gov record NCT04766008, source copy `cardio:ctgov-nct04766008-2022-04-12`, retrieved 2026-10-26)
- Completion: 2022-04-30 (anticipated) (ClinicalTrials.gov record NCT04766008, source copy `cardio:ctgov-nct04766008-2022-04-12`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT04766008, source copy `cardio:ctgov-nct04766008-2022-04-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04766008-2022-04-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Metformin in Diabetic Patients Undergoing Coronary Angiography
- Acronym: NO-STOP
- Condition: Diabetes Mellitus
- Condition: Coronary Artery Disease
- Condition: Lactic Acidosis With Diabetes Mellitus
- Condition: Contrast-induced Nephropathy
- Condition: Metformin Associated Lactic Acidosis
- Intervention (Drug): Metformin
- Lead sponsor: Humanitas Hospital, Italy
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)

## Provenance

Content hash: c9d8d53ccc59ba201d04c02fcf934e20699523df96ffb74763ff0e90eaf4c34d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
